Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Circulating Plasma miRNA-21 as a Superior Biomarker Compared to CA 15-3: Assessment in Healthy Age Matched Subjects and Different Stage of Breast Cancer Patients

The Indonesian Biomedical Journal · Vol. 12 No. 2 (2020) · hlm. 157–164

DOI
10.18585/inabj.v12i2.1142
ISSN
2085-3297, 2355-9179
Terbit
2020-06-29
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Carbohydrate antigens 15-3 (CA 15-3) is a conventional tumor marker in breast cancer, with low sensitivity and specificity. MicroRNA (miRNA)-21 showed its stability in circulation and could serve as powerful biomarker. The aim of this study was to evaluate miRNA-21 as breast cancer biomarker compared to CA 15-3 in Indonesian population.METHODS: Circulating plasma miRNA-21 expression was measured using qRT-PCR in 49 patients at various stages of breast cancer and 16 healthy controls. The relative expression value of miRNA-21 was calculated using 2-ΔΔCt. Meanwhile, CA 15-3 was quantified using electrochemiluminescence immunoassay (ECLIA) methods. The results of miRNA-21 and CA 15-3 plasma circulating expression were compared with controls at each stage and between stages of breast cancer.RESULTS: CA 15-3 median level in breast cancer group was 1.60 times higher compared to control group (p=0.019), 21.00 m/mL and 13.05 m/mL, respectively. Median miRNA-21 expression in breast cancer group was elevated 4.92 folds compared to control group (p=0.001), 4.43 and 0.90, respectively. There was no significant difference of CA 15-3 level between controls and all stages of breast cancer group. CA 15-3 cut-off value was 15.05 m/mL (p=0.016) with 59.2% sensitivity and 62.5% specificity. Meanwhile, there was a significant difference of miRNA-21 expression between controls and most stages of breast cancer group. Circulating miRNA-21 expression cut-off value was 2.07 (p=0.000) with 91.8% sensitivity and 87.5% specificity.CONCLUSION: Circulating miRNA-21 expression and CA 15-3 levels were significantly increased in breast cancer group compared to control group. The miRNA-21 expression increased consistently with breast cancer stage progression. miRNA-21 could serve as superior biomarker compared to CA 15-3.KEYWORDS: biomarker, breast cancer, circulating plasma, liquid biopsy, miRNA-21

Kata kunci

Jaringan kolaborasi para penulis

32 penulis · 146 tautan kepenulisan bersama · 17 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Chulalongkorn University
  • Ollscoil na Gaillimhe – University of Galway
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Siprianus Ugroseno Yudho BintoroUniversitas Airlangga4
Muhammad Noor DiansyahUniversitas Airlangga4
Choirina WindradiUniversitas Airlangga4
Krisnina Nurul WidiyastutiUniversitas Airlangga4
Fedik Abdul RantamUniversitas Airlangga3
I Ketut SudianaUniversitas Airlangga3
Abdurachman AbdurachmanUniversitas Airlangga3
Lukman HakimUniversitas Airlangga3
Reny I’tishomUniversitas Airlangga3
Steven Sheng LooiOllscoil na Gaillimhe – University of Galway3
Suryo KuncorojaktiUniversitas Airlangga1
Yulianna PuspitasariUniversitas Airlangga1
Diena DelaiahUniversitas Airlangga1
Ahmad AswinUniversitas Airlangga1
Helen SusilowatiUniversitas Airlangga1
Firdausy Kurnia MaulanaUniversitas Airlangga1
Diyantoro DiyantoroUniversitas Airlangga1
Watchareewan RodprasertChulalongkorn University1
Yeni DhamayantiUniversitas Airlangga1
Ario DjatmikoAfiliasi tidak diketahui1
Wiwien RistantoAfiliasi tidak diketahui1
Lies MardiyanaAfiliasi tidak diketahui1
Sindrawati SindrawatiAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Circulating Plasma miRNA-21 as a Superior Biomarker Compared to CA 15-3: Assessment in Healthy Age Matched Subjects and Different Stage of Breast Cancer Patients</dc:title><dc:creator>Merlyna Savitri</dc:creator><dc:creator>Ugroseno Yudho Bintoro</dc:creator><dc:creator>Made Putra Sedana</dc:creator><dc:creator>Muhammad Noor Muhammad</dc:creator><dc:creator>Pradana Zaky Romadhon</dc:creator><dc:creator>Putu Niken Ayu Amrita</dc:creator><dc:creator>Andi Yasmin Wijaya</dc:creator><dc:creator>Winona May Hendrata</dc:creator><dc:creator>Ami Ashariati</dc:creator><dc:subject>miR-21</dc:subject><dc:subject>CA15-3</dc:subject><dc:subject>breast cancer biomarkers</dc:subject><dc:subject>circulating microRNAs</dc:subject><dc:subject>liquid biopsy</dc:subject><dc:subject>tumor stage</dc:subject><dc:subject>sensitivity and specificity</dc:subject><dc:subject>Indonesian population</dc:subject><dc:subject>plasma biomarkers</dc:subject><dc:subject>breast cancer staging</dc:subject><dc:subject>Indonesian</dc:subject><dc:description xml:lang="en">BACKGROUND: Carbohydrate antigens 15-3 (CA 15-3) is a conventional tumor marker in breast cancer, with low sensitivity and specificity. MicroRNA (miRNA)-21 showed its stability in circulation and could serve as powerful biomarker. The aim of this study was to evaluate miRNA-21 as breast cancer biomarker compared to CA 15-3 in Indonesian population.METHODS: Circulating plasma miRNA-21 expression was measured using qRT-PCR in 49 patients at various stages of breast cancer and 16 healthy controls. The relative expression value of miRNA-21 was calculated using 2-ΔΔCt. Meanwhile, CA 15-3 was quantified using electrochemiluminescence immunoassay (ECLIA) methods. The results of miRNA-21 and CA 15-3 plasma circulating expression were compared with controls at each stage and between stages of breast cancer.RESULTS: CA 15-3 median level in breast cancer group was 1.60 times higher compared to control group (p=0.019), 21.00 m/mL and 13.05 m/mL, respectively. Median miRNA-21 expression in breast cancer group was elevated 4.92 folds compared to control group (p=0.001), 4.43 and 0.90, respectively. There was no significant difference of CA 15-3 level between controls and all stages of breast cancer group. CA 15-3 cut-off value was 15.05 m/mL (p=0.016) with 59.2% sensitivity and 62.5% specificity. Meanwhile, there was a significant difference of miRNA-21 expression between controls and most stages of breast cancer group. Circulating miRNA-21 expression cut-off value was 2.07 (p=0.000) with 91.8% sensitivity and 87.5% specificity.CONCLUSION: Circulating miRNA-21 expression and CA 15-3 levels were significantly increased in breast cancer group compared to control group. The miRNA-21 expression increased consistently with breast cancer stage progression. miRNA-21 could serve as superior biomarker compared to CA 15-3.KEYWORDS: biomarker, breast cancer, circulating plasma, liquid biopsy, miRNA-21</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2020-06-29</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v12i2.1142</dc:identifier><dc:identifier>10.18585/inabj.v12i2.1142</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 12 No 2 (2020); 157-164</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/1142/479</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>